Shane Smith
About Shane Smith
Shane Smith serves as the Vice President of Clinical Operations at Capricor Therapeutics, Inc., a position he has held since 2014. He has extensive experience in clinical operations, having previously worked at Genentech and Nektar Therapeutics in various roles.
Work at Capricor Therapeutics
Shane Smith has been serving as the Vice President of Clinical Operations at Capricor Therapeutics, Inc. since 2014. In this role, he oversees the clinical development of innovative therapies, ensuring that clinical trials are conducted efficiently and in compliance with regulatory standards. His leadership contributes to the advancement of Capricor's pipeline, which focuses on regenerative medicine and cell therapy.
Previous Experience at Genentech
Shane Smith held multiple positions at Genentech, a leading biotechnology company, from 2005 to 2011. He began as a Clinical Trial Manager III, progressing to Clinical Program Leader and then Senior Clinical Program Leader in the Research and Early Development division. His tenure at Genentech spanned six years, during which he gained extensive experience in clinical program management and trial execution.
Experience at Nektar Therapeutics
From 2012 to 2014, Shane Smith worked as the Director of Clinical Operations at Nektar Therapeutics in San Francisco, California. In this position, he was responsible for overseeing clinical trials and managing operational aspects of the clinical development process. His work contributed to the advancement of Nektar's drug development initiatives.
Education and Expertise
Shane Smith studied at the University of Arkansas, where he acquired foundational knowledge and skills relevant to his career in clinical operations. His educational background supports his expertise in managing complex clinical trials and navigating the regulatory landscape in the biotechnology industry.